Eric I Richman insider trades: Gain Therapeutics (GANX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | GANX | ↑ Buy | 17,000 | $1.22 | $21K | Direct | Jul 1, 2024 (0d) |
| May 25, 2022 | GANX | ↑ Buy | 2,482 | $2.58 | $6K | Direct | May 27, 2022 (2d) |
| May 20, 2022 | GANX | ↑ Buy | 9,256 | $2.83 | $26K | Direct | May 23, 2022 (3d) |
| May 19, 2022 | GANX | ↑ Buy | 4,000 | $2.71 | $11K | Direct | May 23, 2022 (4d) |
| Mar 4, 2022 | NBSE | ↑ Buy | 3,880 | $1.64 | $6K | Direct | Mar 7, 2022 (3d) |
| Apr 26, 2021 | NBSE | ↑ Buy | 5,000 | $5.00 | $25K | Direct | Apr 27, 2021 (1d) |
| Apr 30, 2020 | NBSE | ↑ Buy | 8,333 | $6.00 | $50K | Direct | May 4, 2020 (4d) |
| Apr 30, 2020 | NBSE | ↑ Buy | 2,500 | $6.00 | $15K | Indirect | May 4, 2020 (4d) |
| Jun 8, 2018 | ADMA | ↑ Buy | 5,230 | $4.78 | $25K | Direct | Jun 11, 2018 (3d) |
| Nov 9, 2017 | ADMA | ↑ Buy | 25,000 | $2.15 | $54K | Direct | Nov 13, 2017 (4d) |
| Apr 13, 2016 | PIP | ↓ Sell | 329,354 | $2.20 | $725K | Direct | Apr 15, 2016 (2d) |
| Apr 8, 2016 | PIP | ↓ Sell | 11,767 | $2.20 | $26K | Direct | Apr 11, 2016 (3d) |
| Mar 13, 2015 | ADMA | ↑ Buy | 3,500 | $7.88 | $28K | Direct | Mar 17, 2015 (4d) |
| Nov 10, 2011 | PIP | ↑ Buy | 10,000 | $1.50 | $15K | Indirect | Nov 14, 2011 (4d) |
| Jun 17, 2010 | PIP | ↑ Buy | 10,000 | $1.58 | $16K | Direct | Jun 21, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Eric I Richman's insider trades
Eric I Richman is a director at Gain Therapeutics (GANX). Since Jun 17, 2010, Eric has reported 13 open-market purchases worth $298K and 2 sales worth $750K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (33 filings), option exercises (7 filings), shares withheld for taxes (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GANX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.